Description
DESCRIPTION: Glem-Lin is a combination of Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and Linagliptin, a dipeptidyl peptidase-4 (DPP- 4) inhibitor, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both …
Additional information
| brand | Nabiqasim Industries |
|---|
